| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| June 8, 2026 | ±3.1% | -0.9% | over-priced |
| March 11, 2026 | ±3.2% | -7.0% | under-priced |
| June 2, 2025 | ±2.4% | +0.6% | over-priced |
| March 5, 2025 | ±3.5% | -2.9% | over-priced |
| December 4, 2024 | ±1.5% | -6.2% | under-priced |
| June 5, 2024 | ±1.7% | -0.2% | over-priced |
| March 6, 2024 | ±1.6% | +0.8% | over-priced |
| December 6, 2023 | ±1.9% | +7.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $0.41 | $2.4B | $124M |
| Q2 FY2026 | $0.48 | $2.6B | $145M |
| Q1 FY2026 | $0.65 | $2.7B | $194M |
| Q4 FY2025 | $0.49 | $2.3B | $145M |
The Campbell's Company Common Stock (CPB) reports in 132 days, with the next report estimated for October 23, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 3.2% on average — the market has been roughly fair on CPB's earnings risk. Fundamentals into the print: EPS up 86.4% year-over-year, revenue down 4.4%. QuantLogix's live 5-factor engine currently reads CPB as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →